What the company does
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and …
What the weekly tape is saying
4875 closed the latest completed week at 199.0 JPY. The 4-week return is -7.9% and the 12-week return is -12.3%. Trend Signal is inactive, Market Dynamics is -1.09. Setup signature: Risk-first tape with a 22/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 232.7 JPY
- Vs Trend Line
- -14.5%
- Fair Value
- 244.2 JPY
- Vs Fair Value
- -18.5%
- 52W High
- 314.0 JPY
- 52W Low
- 174.0 JPY
- Drawdown
- -36.6%
- Range Position
- 17.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 19
- 52W Active Breadth
- 36.5%
- Sector Scope
- JP Healthcare
- Sector Rank
- 179 of 223
- Sector Percentile
- 19.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Biotechnology
- Tracked Peers
- 48
- 4W Rank
- 10 of 48
- Avg 1W
- -6.1%
- Avg 4W
- -16.7%
- Trend Breadth
- 12.5%
- Positive RS
- 2.1%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.09
- 4W MD Change
- 6.4%
- Relative Strength
- -30.21
- 4W RS Change
- -40.0%
- Expectation
- Undecided
- Probability
- 45.30%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 250.1K
- 13W Average
- 196.8K
- 52W Average
- 504.2K
- Vs 13W
- 1.3x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.5%
- 52W Volatility
- 5.9%
- Upside Weeks
- 23
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 5.1% / -3.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- JPY
- Market Cap
- 10.7B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 199.0 JPY | -6.1% | 232.7 JPY | 244.2 JPY | -1.09 | -30.21 | 250.1K | Off |
| 5 Jun 2026 | 212.0 JPY | -2.3% | 234.1 JPY | 245.0 JPY | -1.06 | -27.04 | 191.2K | Off |
| 29 May 2026 | 217.0 JPY | -3.6% | 234.8 JPY | 245.6 JPY | -1.03 | -25.78 | 257.2K | Off |
| 22 May 2026 | 225.0 JPY | 4.2% | 235.1 JPY | 246.1 JPY | -1.11 | -20.16 | 180.5K | Off |
| 15 May 2026 | 216.0 JPY | -2.7% | 233.7 JPY | 246.6 JPY | -1.16 | -21.58 | 220.9K | Off |
| 8 May 2026 | 222.0 JPY | -1.8% | 232.6 JPY | 247.2 JPY | -1.12 | -21.69 | 66.7K | Off |
| 1 May 2026 | 226.0 JPY | 4.6% | 231.4 JPY | 247.7 JPY | -1.02 | -16.79 | 116.6K | Off |
| 24 Apr 2026 | 216.0 JPY | -5.3% | 229.8 JPY | 248.2 JPY | -0.94 | -21.43 | 223.0K | Off |
| 17 Apr 2026 | 228.0 JPY | -0.9% | 228.9 JPY | 248.6 JPY | -0.84 | -16.19 | 176.3K | Off |
| 10 Apr 2026 | 230.0 JPY | 2.7% | 227.5 JPY | 249.1 JPY | -0.82 | -13.97 | 92.4K | Off |
| 3 Apr 2026 | 224.0 JPY | -2.6% | 226.3 JPY | 249.6 JPY | -0.87 | -11.04 | 131.1K | Off |
| 27 Mar 2026 | 230.0 JPY | 1.3% | 225.4 JPY | 250.0 JPY | -0.76 | -9.69 | 318.5K | On |
| 20 Mar 2026 | 227.0 JPY | 3.7% | 224.5 JPY | 250.4 JPY | -0.52 | -11.50 | 334.4K | On |
| 13 Mar 2026 | 219.0 JPY | -6.8% | 223.4 JPY | 250.8 JPY | -0.29 | -15.98 | 292.3K | On |